[7] PharmaCotherapia d.o.o., Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source., clinicaltrials.gov, Clinical trial registration NCT02637284, Dec
One trial included healthy non-obese participants, demonstrating that the favorable safety profile was not unique to obese individuals
Eating smaller meals more frequently works better
Note that tirzepatide has mild and severe side effects if youre considering it
Step 1: Set Your Dose Choose the desired dose in micrograms (mcg)
However, the interactions have not been studied